Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Tg Therapeutics (TGTX) Shares Repurchased (2024 - 2025)

Tg Therapeutics has reported Shares Repurchased over the past 2 years, most recently at $78.2 million for Q3 2025.

  • Quarterly results put Shares Repurchased at $78.2 million for Q3 2025, up 3540.86% from a year ago — trailing twelve months through Dec 2025 was $91.2 million (up 941.55% YoY), and the annual figure for FY2025 was $91.2 million, up 941.55%.
  • Shares Repurchased for Q3 2025 was $78.2 million at Tg Therapeutics, up from $6.9 million in the prior quarter.
  • Over the last five years, Shares Repurchased for TGTX hit a ceiling of $78.2 million in Q3 2025 and a floor of $2.1 million in Q3 2024.